Clinical Trial Update: Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how water and food intake affect the pharmacokinetics and pharmacodynamics of oral salmon calcitonin in postmenopausal women with postm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Oral Salmon Calcitonin (salmon calcitonin)

Snippet

Sponsor: Novartis | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED